Medications for Idiopathic Hypogonadotropic Hypogonadism

24 results

  • Azmiro (testosterone cypionate)

    (TESTOSTERONE CYPIONATE)
    Azurity Pharmaceuticals, Inc.
    Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.

  • Depo-testosterone (testosterone cypionate)

    (testosterone cypionate)
    Pharmacia and Upjohn Company LLC
    Usage: DEPO-Testosterone Injection is indicated for replacement therapy in men with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin deficiency). Its safety and efficacy for "age-related hypogonadism" have not been established.

  • Kyzatrex (testosterone undecanoate)

    (TESTOSTERONE UNDECANOATE)
    Marius Pharmaceuticals
    Usage: KYZATREX™ is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). Safety and efficacy in males under 18 have not been established.

  • Methyltestosterone (methyltestosterone)

    (METHYLTESTOSTERONE)
    Amneal Pharmaceuticals of New York LLC
    Usage: Androgens are indicated for testosterone replacement therapy in males with primary and hypogonadotropic hypogonadism, and for stimulating puberty in selected cases. In females, they are used in treating advanced inoperable metastatic breast cancer post-menopause. Treatment decisions should involve expert judgment, especially in oncology.

  • Pregnyl (choriogonadotropin alfa)

    (CHORIOGONADOTROPIN ALFA)
    Organon LLC
    Usage: hCG is indicated for prepubertal cryptorchidism not due to anatomical obstruction, selected cases of hypogonadotropic hypogonadism in males, and induction of ovulation in anovulatory, infertile women after appropriate treatment with human gonadotropins. It is not effective for weight loss or obesity treatment.

  • Striant (testosterone)

    (testosterone)
    Columbia Laboratories, Inc.
    Usage: Striant® is indicated for replacement therapy in males with testosterone deficiency due to conditions like primary hypogonadism (testicular failure) and hypogonadotropic hypogonadism (gonadotropin or LHRH deficiency). It is used when serum testosterone levels are low, with varying gonadotropin levels.

  • Testo-200 (testosterone cypionate inj.)

    (testosterone cypionate inj.)
    Advanced Pharmaceutical Technology, Inc.
    Usage: Testosterone Cypionate Injection, USP is indicated for replacement therapy in males with conditions causing symptoms of testosterone deficiency, including primary and hypogonadotropic hypogonadism due to various causes like testicular failure, hormonal deficiencies, or injuries affecting the pituitary or hypothalamus.

  • Testone cik (testosterone cypionate, alcohol)

    (Testosterone Cypionate, Alcohol)
    Asclemed USA, Inc.
    Usage: Testosterone cypionate injection is indicated for replacement therapy in males with symptoms of testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin or LHRH deficiency). Its safety and efficacy in age-related hypogonadism are not established.

  • Testopel (testosterone)

    (TESTOSTERONE)
    Slate Pharma
    Usage: Androgens are indicated for replacement therapy in males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. They may also be used to stimulate puberty in selected males with delayed puberty. Prolonged treatment is necessary to maintain sexual characteristics after puberty. Bone maturation effects should be monitored.

  • Testosterone (testosterone)

    (Testosterone)
    Dr. Reddy's Laboratories Inc.
    Usage: Testosterone gel 1.62% is indicated for replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to conditions like testicular failure or pituitary-hypothalamic injury. Its safety and efficacy for age-related hypogonadism and in males under 18 have not been established.